Efficacy of Ketoconazole v Nystatin in Prevention of Fungal Infections in Neutropenic Patients

Archives of Internal Medicine

Volumn 144, Issue 3, 1984, Pages 549-551

  Jones, Paula G ^a,b   Kauffman, Carol A ^a   Mcauliffe, Lawrence S ^a,c   Liepman, Marcia K ^a,d   Bergman, Alice G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c East Main Street Medical Associates ^*  (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOCONAZOLE; NYSTATIN;

BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL ARTICLE; DRUG THERAPY; ESOPHAGITIS; ESOPHAGUS; FEMALE GENITAL SYSTEM; FUNGUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MYCOSIS; NEUTROPENIA; ORAL DRUG ADMINISTRATION; RETICULOENDOTHELIAL SYSTEM; THERAPY; THRUSH; VAGINITIS;

ADULT; AGRANULOCYTOSIS; FEMALE; HUMANS; KETOCONAZOLE; MALE; MIDDLE AGED; MYCOSES; NEUTROPENIA; NYSTATIN; PROSPECTIVE STUDIES; RANDOM ALLOCATION;

EID: 84941814349     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1984.00350150149034     Document Type: Article

References (20)

1. Meunier-Carpentier F, Kiehn TE, Armstrong D: Fungemia in the immunocompromised host: Changing patterns, antigenemia, high mortality. Am J Med 1981;71:363-370.
2. Bodey GP, Bolivar R, Fainstein V: Infectious complications in leukemic patients. Semin Hematol 1982;19:193-226.
3. Van der Waaij D, Vossen JM, Hartgrink CA, et al: Polyene antibiotics in the prevention of Candida albicans colonization in the digestive tract of patients with severely decreased resistance to infections, in Van der Waaij D, Verhoef (eds): New Criteria for Antimicrobial Therapy: Maintenance of Digestive Tract Colonization Resistance. Amsterdam, Excerpta Medica, 1979, pp 135-144.
4. Bodey GP, Rosenbaum B: Effect of prophylactic measures on the microbial flora of patients in protected environment units. Medicine 1974;53:209-228.
5. Brincker H: Prophylactic treatment with miconazole in patients highly predisposed to fungal infection. Acta Med Scand 1978;204:123-128.
6. Petersen EA, Alling DW, Kirkpatrick CH: Treatment of chronic mucocutaneous candidiasis. Ann Intern Med 1980;93:791-795.
7. Mirsky HS, Cuttner J: Fungal infection in acute leukemia. Cancer 1972;30:348-352.
8. Levine AS, Schimpff SC, Graw RG Jr, et al: Hematologic malignancies and other marrow failure states: Progress in the management of complicating infections. Semin Hematol 1974;11:141-202.
9. Mackenzie DWR: Yeasts from human sources. Sabouraudia 1961;1: 8-15.
10. Wingard JR, Dick JD, Merz WG, et al: Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect Immun 1980;29:808-813.
11. Seelig MS: The role of antibiotics in the pathogenesis of Candida infections. Am J Med 1966;40:887-917.
12. DeGregorio MW, Lee WMF, Ries CA: Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 1982;50:2780-2784.
13. De Vries-Hospers HG, Mulder NH, Sleijfer DT, et al: The effect of amphotericin B lozenges on the presence and number of Candida cells in the oropharynx of neutropenic leukemic patients. Infection 1982;10:71-75.
14. Ezdinli EZ, O’Sullivan DD, Wasser LP, et al: Oral amphotericin for candidiasis in patients with hematologic neoplasms. JAMA 1979;242:258-260.
15. Carpentieri U, Haggard ME, Lockhart LH, et al: Clinical experience in prevention of candidiasis by nystatin in children with acute lymphocytic leukemia. J Pediatr 1978;92:593-595.
16. Hann IM, Corringham R, Keaney M, et al: Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet 1982;1:826-829.
17. Meunier-Carpentier F, Cruciani M, Klastersky J: Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients. Eur J Cancer Clin Oncol 1983;19:43-48.
18. Kauffman CA, Liepman MK, Bergman AG, et al: Trimethoprim/ sulfamethoxazole prophylaxis in neutropenic patients: Reduction of infections and effect on bacterial and fungal flora. Am J Med 1983;74:599-608.
19. Acuna G, Winston DJ, Young LS: Ketoconazole prophylaxis of fungal infections in the granulocytopenic patient, abstract 852. Program and abstracts of the 21st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, October 1981.
20. De Jongh C, Finley R, Joshi J, et al: A comparison of ketoconazole to nystatin: Prophylaxis of fungal infection in neutropenic patients, abstract 497. Program and abstracts of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Miami, October 1982.